Skip to main content
. 2023 May 18;13(5):e068147. doi: 10.1136/bmjopen-2022-068147

Table 1.

Study schedule

Assessment no 1 2 3 4 5
Assessment timing Day −90 to 0 before surgery Day 1 after surgery on ward Day 2 after surgery on ward Day 3 after surgery on ward Day 30 after surgery +30 days to allow time to review postoperative investigations and supporting information
Clinical history Assessment
Eligibility criteria X
Informed consent X
Demographics X
Past medical history X
Height X
Weight X
Surgery type X
Laboratory tests
Haemoglobin X
Serum creatinine X
BNP X
Point-of-care NT-pro-BNP X
hsTnI X X X
Clinical outcomes
Death X
Vascular death X
MINS (including MI and isolated-ischaemic troponin elevation) X
Stroke X
Cardiac arrest X
Major bleed X
Congestive heart failure X
Coronary artery revascularisation X
Pulmonary embolus X
Pneumonia X
Sepsis X
New atrial fibrillation X

BNP, B-type natriuretic peptide; hsTnI, high sensitivity troponin I; MI, myocardial infarction; MINS, myocardial injury after non-cardiac surgery; NT-pro-BNP, N-terminal pro-BNP.